company background image
SIBN logo

SI-BONE NasdaqGM:SIBN Stock Report

Last Price

US$12.15

Market Cap

US$509.5m

7D

-2.3%

1Y

-32.2%

Updated

21 Nov, 2024

Data

Company Financials +

SIBN Stock Overview

A medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. More details

SIBN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

SI-BONE, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SI-BONE
Historical stock prices
Current Share PriceUS$12.15
52 Week HighUS$21.70
52 Week LowUS$11.76
Beta1.23
11 Month Change-6.39%
3 Month Change-26.59%
1 Year Change-32.24%
33 Year Change-42.25%
5 Year Change-31.47%
Change since IPO-39.43%

Recent News & Updates

Market Cool On SI-BONE, Inc.'s (NASDAQ:SIBN) Revenues

Nov 04
Market Cool On SI-BONE, Inc.'s (NASDAQ:SIBN) Revenues

Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Sep 25
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Recent updates

Market Cool On SI-BONE, Inc.'s (NASDAQ:SIBN) Revenues

Nov 04
Market Cool On SI-BONE, Inc.'s (NASDAQ:SIBN) Revenues

Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Sep 25
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

SI-BONE, Inc.'s (NASDAQ:SIBN) P/S Is On The Mark

Apr 01
SI-BONE, Inc.'s (NASDAQ:SIBN) P/S Is On The Mark

Analyst Estimates: Here's What Brokers Think Of SI-BONE, Inc. (NASDAQ:SIBN) After Its Full-Year Report

Feb 29
Analyst Estimates: Here's What Brokers Think Of SI-BONE, Inc. (NASDAQ:SIBN) After Its Full-Year Report

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Feb 28
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Nov 12
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Aug 09
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Is SI-BONE (NASDAQ:SIBN) A Risky Investment?

Apr 20
Is SI-BONE (NASDAQ:SIBN) A Risky Investment?

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Jan 01
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Sep 24
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

SI-BONE (NASDAQ:SIBN) Has Debt But No Earnings; Should You Worry?

Apr 19
SI-BONE (NASDAQ:SIBN) Has Debt But No Earnings; Should You Worry?

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Jan 05
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Oct 05
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Shareholder Returns

SIBNUS Medical EquipmentUS Market
7D-2.3%-0.4%-1.0%
1Y-32.2%20.3%30.3%

Return vs Industry: SIBN underperformed the US Medical Equipment industry which returned 20.9% over the past year.

Return vs Market: SIBN underperformed the US Market which returned 30.4% over the past year.

Price Volatility

Is SIBN's price volatile compared to industry and market?
SIBN volatility
SIBN Average Weekly Movement9.4%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.2%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Stable Share Price: SIBN has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: SIBN's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2008344Laura Francissi-bone.com

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion.

SI-BONE, Inc. Fundamentals Summary

How do SI-BONE's earnings and revenue compare to its market cap?
SIBN fundamental statistics
Market capUS$509.55m
Earnings (TTM)-US$37.40m
Revenue (TTM)US$157.04m

3.2x

P/S Ratio

-13.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SIBN income statement (TTM)
RevenueUS$157.04m
Cost of RevenueUS$35.02m
Gross ProfitUS$122.02m
Other ExpensesUS$159.42m
Earnings-US$37.40m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.89
Gross Margin77.70%
Net Profit Margin-23.82%
Debt/Equity Ratio21.9%

How did SIBN perform over the long term?

See historical performance and comparison